• Hepatic Hippo signaling inhibits development of hepatocellular carcinoma

• Liu Yuchen

• Wang Xiaohui, Yang Yingzi

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 742 ~ 750

• Alcohol and hepatocarcinogenesis

• Taniai Makiko

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 736 ~ 741

• Nonalcoholic fatty liver disease and alcohol-related liver disease: From clinical aspects to pathoph...

• Ikejima Kenichi

• Kon Kazuyoshi, Yamashina Shunhei

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 728 ~ 735

• Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseas...

• Kim Yun-Seok

• Kim Sang-Geon

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 715 ~ 727

• Long non-coding RNAs in liver diseases: Focusing on nonalcoholic fatty liver disease, alcohol-relate...

• Han Sen

• Zhang Ting, Kusumanchi Praveen, Huda Nazmul, Jiang Yanchao, Yang Zhihong, Liangpunsakul Suthat

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 705 ~ 714

• Oxidative stress and glutamate excretion in alcoholic steatosis: Metabolic synapse between hepatocyt...

• Kim Hee-Hoon

• Choi Sung-Eun, Jeong Won-Il

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 697 ~ 704

• Emerging medical therapies for severe alcoholic hepatitis

• Tornai David

• Szabo Gyongyi

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 686 ~ 696

• Roles of the complement system in alcohol-induced liver disease

• Zhou Yi

• Yuan Guandou, Zhong Fudi, He Songqing

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 677 ~ 685

• Liver-lung axes in alcohol-related liver disease

• Arteel Gavin E.

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 670 ~ 676

• The effect of moderate alcohol drinking in nonalcoholic fatty liver disease

• Choi Jong-Hwa

• Sohn Won, Cho Yong-Kyun

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 662 ~ 669

• Global and regional impacts of alcohol use on public health: Emphasis on alcohol policies

• Park Seung-Ha

• Kim Dong-Joon

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 652 ~ 661

• Predictors of steroid non-response and new approaches in severe alcoholic hepatitis

• Sarin Shiv Kumar

• Sharma Shvetank

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 639 ~ 651

• The lymphatic system in alcohol-associated liver disease

• Kondo Reiichiro

• Iwakiri Yasuko

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 633 ~ 638

• Inter-professional and inter-departmental alcoholism rehabilitation program

• Kikuchi Masahiro

• Matsutani Naomi, Ishihara Ryota, Sugihara Masako, Mizuno Yuuki, Chiba Chiyo, Ohta Takahiro,&nbs...

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 626 ~ 632

• Programmed cell death in alcohol-associated liver disease

• Miyata Tatsunori

• Nagy Laura E.

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 618 ~ 625

• Autophagy and liver cancer

• Chao Xiaojuan

• Qian Hui, Wang Shaogui, Fulte Sam, Ding Wen-Xing

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 606 ~ 617

• From intestinal dysbiosis to alcohol-associated liver disease

• Mendes Beatriz Garcia

• Schnabl Bernd

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 595 ~ 605

• Obesity and binge alcohol intake are deadly combination to induce steatohepatitis: A model of high-f...

• Hwang Seong-Hwan

• Ren Tianyi, Gao Bin

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 586 ~ 594

• The 14th International Symposium on Alcoholic Liver and Pancreatic Diseases and Cirrhosis (ISALPDC)

• Kim Dong-Joon

• Jeong Won-Il, Tsukamoto Hidekazu, Gao Bin

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 584 ~ 585

• Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic ...

• Patoulias Dimitrios

• Doumas Michael

• Clinical and Molecular Hepatology   2020  Volume.26  No.4 582 ~ 583